- Home
- NAUT vs EIKN Comparison
NAUT vs EIKN Comparison
Compare NAUT & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAUT | EIKN |
|---|---|---|
| Founded | 2016 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 347.7M | 401.9M |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | NAUT | EIKN |
|---|---|---|
| Price | $2.30 | $5.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $4.00 | ★ $24.33 |
| AVG Volume (30 Days) | ★ 11.5M | 528.2K |
| Earning Date | 10-27-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.07 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $708.84 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.84 | $5.01 |
| 52 Week High | $4.31 | $16.50 |
Technical Indicators
Market Signals| Indicator | NAUT | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 50.73 | 33.87 |
| Support Level | $2.03 | N/A |
| Resistance Level | $2.32 | $8.48 |
| Average True Range (ATR) | 0.49 | 0.69 |
| MACD | -0.03 | -0.14 |
| Stochastic Oscillator | 26.95 | 19.34 |
Price Performance
Historical ComparisonAbout NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.